These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7904188)

  • 41. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Omeprazole ameliorates aspirin-induced gastroduodenal injury.
    Scheiman JM; Behler EM; Loeffler KM; Elta GH
    Dig Dis Sci; 1994 Jan; 39(1):97-103. PubMed ID: 8281875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of H2-receptor blockers in the prevention of gastric injury resulting from nonsteroidal anti-inflammatory agents.
    Kimmey MB; Silverstein FE
    Am J Med; 1988 Feb; 84(2A):49-52. PubMed ID: 3258124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor.
    Konturek SJ; Konturek JW; Kwiecien N; Obtułowicz W; Oleksy J; Hebzda Z; Amon I
    Scand J Gastroenterol; 1991 Mar; 26(3):231-6. PubMed ID: 1853145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
    Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man.
    Moore JG; Goo RH
    Chronobiol Int; 1987; 4(1):111-6. PubMed ID: 3677213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
    Oddsson E; Gudjónsson H; Thjódleifsson B
    Scand J Gastroenterol; 1992 Dec; 27(12):1045-8. PubMed ID: 1475621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
    Müller P; Simon B
    Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
    Müller P; Simon B
    Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
    Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.
    Daneshmend TK; Stein AG; Bhaskar NK; Hawkey CJ
    Br J Clin Pharmacol; 1989 Jul; 28(1):109-12. PubMed ID: 2789070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine bismuth citrate.
    Chiba N; Hunt RH; Thomson AB
    Can J Gastroenterol; 2001 Jun; 15(6):389-98. PubMed ID: 11429668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Protective effect of compound bismuth and magnesium granules on aspirin-induced gastric mucosal injury in rats].
    Mu FH; Hu FL; Wei H; Zhang YY; Yang GB; Lei XY; Yang YP; Sun WN; Cui MH
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):464-7. PubMed ID: 26875925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protective effect of ranitidine and bismuth salts on gastritis induced by ethanol].
    Nishimura M; Angelosante S; Lecuna V
    G E N; 1993; 47(4):209-14. PubMed ID: 8050697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
    Konturek SJ; Kwiecień N; Obtułowicz W; Kopp B; Oleksy J
    Gut; 1986 Dec; 27(12):1450-6. PubMed ID: 3492413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
    Cavanagh RL; Buyniski JP; Schwartz SE
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.